This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Advisory Board Company To Highlight New Technology Capabilities That Support Accountable Care

Stocks in this article: ABCO

The session will include a reactor panel of Accountable Care Organizations and experts who will discuss the impact and value of Crimson.

In addition to the June 6 presentation, Mr. Cinque will provide insights from the firm's experiences impactfully leveraging CMS data.  This discussion will be part of a breakout panel session entitled "How to Turn Data into Meaningful Information for Business Problems; Strategy, Practice and Games for Start Ups and Status Quos with Examples from CMS Data,"  in Room 101 from 1:30-5:30 pm EDT on Tuesday, June 5

Across the country, health care providers are utilizing The Advisory Board Company's Crimson suite of products, including a cohort focused specifically on leveraging Crimson to manage population risk more effectively.  "Crimson services have played a strategic role in our ability to structure risk-based contracts with payers," said Charles Kelly, D.O., President and CEO, Henry Ford Physician Network, a physician-led subsidiary of Henry Ford Health System that focuses on delivering higher quality care while reducing medical costs through collaborative best practices, evidence-based medicine and improved efficiency.  "Crimson has enabled us to understand and improve our performance on controlled populations and has given us the confidence to pursue additional risk-based contracts."  

The Advisory Board Company is a global technology, research, and consulting firm partnering with 140,000 leaders in 3,700 organizations across health care and higher education.  Through its Crimson offerings, The Advisory Board Company collaborates with health care providers dedicated to strengthening hospital-physician alignment, coordination among care settings, and overall clinical performance. 

For more information on Crimson and managing population risk, visit The Advisory Board Company's booth No. 2 (West Salon) at the HDI Forum or see the firm's Web resources for managing population risk at http://www.advisory.com/Technology/Crimson-Population-Risk-Management

About The Advisory Board Company 

The Advisory Board Company is a global technology, research, and consulting firm partnering with 140,000 leaders in 3,700 organizations across health care and higher education.  Through its innovative membership model, The Advisory Board Company collaborates with executives and their teams to elevate performance and solve their most pressing challenges.  The company provides strategic guidance, actionable insights, web-based software solutions, and comprehensive implementation and management services.  Through its Crimson offerings, The Advisory Board Company collaborates with health care providers dedicated to strengthening hospital-physician alignment, coordination among care settings, and overall clinical performance.  Combining business intelligence technology with best practice implementation, Crimson offerings are developed with hospitals, health systems, physicians, and other practitioners seeking improved alignment on key clinical, operational and strategic goals.  For more information about The Advisory Board Company, visit http://www.advisory.com.

SOURCE The Advisory Board Company

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.25 +19.09 0.95%
NASDAQ 4,683.4070 +45.4130 0.98%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs